Effectiveness Of Second Line Biologic Use In Rheumatoid Arthritis After Switching From First-Line Biologics
Abstract
Authors
V.F. Schabert J. Yeaw J. Korn C. Quach D.J. Harrison H. Yun G. Joseph D. Collier J. Curtis
V.F. Schabert J. Yeaw J. Korn C. Quach D.J. Harrison H. Yun G. Joseph D. Collier J. Curtis
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now